BackIterum Therapeutics Plc Overview

Iterum Therapeutics Plc Total Liabilities

Track Iterum Therapeutics Plc's total liabilities ($40M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$39.88M
↑ 45.40% YoYΔ $12.45M vs prior year quarter

Peer trimmed avg / median

Loading

Iterum Therapeutics Plc Total Liabilities History

Loading

Iterum Therapeutics Plc vs. peers: Total Liabilities Comparison

Loading

Iterum Therapeutics Plc Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Iterum Therapeutics Plc (ITRM) FAQ

As of the most recent data (September 2025), ITRM shows a total liabilities of $40M. That compares with $27M in the prior-year period — up 45.4% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ITRM's total liabilities is now $40M (was $27M) — a 45.4% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Iterum Therapeutics Plc is outperforming or lagging.

Tracking ITRM's total liabilities over time shows whether Iterum Therapeutics Plc is scaling, shrinking, or reshaping that part of the business. The current reading is $40M That compares with $27M in the prior-year period — up 45.4% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total liabilities page, Stockcircle has Iterum Therapeutics Plc's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total liabilities (currently $40M) with ownership activity and broader fundamentals.

Iterum Therapeutics Plc's total liabilities is $40M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.